Outset Medical [OM] vs Abbott Laboratories [ABT] Detailed Stock Comparison
Outset Medical
NASDAQ
Loading...
Abbott Laboratories
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Outset Medical wins in 7 metrics, Abbott Laboratories wins in 11 metrics, with 0 ties. Abbott Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Outset Medical | Abbott Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.36 | 16.53 | Outset Medical |
| Price-to-Book Ratio | 1.57 | 4.53 | Outset Medical |
| Debt-to-Equity Ratio | 63.59 | 26.50 | Abbott Laboratories |
| PEG Ratio | 0.00 | 0.45 | Outset Medical |
| EV/EBITDA | -2.19 | 20.59 | Outset Medical |
| Profit Margin (TTM) | -82.06% | 32.43% | Abbott Laboratories |
| Operating Margin (TTM) | -53.68% | 19.73% | Abbott Laboratories |
| EBITDA Margin (TTM) | N/A | 19.73% | N/A |
| Return on Equity | -87.65% | 30.93% | Abbott Laboratories |
| Return on Assets (TTM) | -15.79% | 6.62% | Abbott Laboratories |
| Free Cash Flow (TTM) | $-117.22M | $6.35B | Abbott Laboratories |
| Dividend Yield | N/A | 1.28% | N/A |
| 1-Year Return | 28.48% | 17.14% | Outset Medical |
| Price-to-Sales Ratio (TTM) | 1.99 | 5.32 | Outset Medical |
| Enterprise Value | $155.36M | $235.76B | Abbott Laboratories |
| EV/Revenue Ratio | 1.30 | 5.47 | Outset Medical |
| Gross Profit Margin (TTM) | 37.77% | 56.44% | Abbott Laboratories |
| Revenue per Share (TTM) | $15 | $25 | Abbott Laboratories |
| Earnings per Share (Diluted) | $-18.75 | $7.97 | Abbott Laboratories |
| Beta (Stock Volatility) | 2.14 | 0.71 | Abbott Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Outset Medical vs Abbott Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Outset Medical | 2.47% | 6.05% | -21.93% | -26.51% | 4.19% | -22.11% |
| Abbott Laboratories | -0.33% | 2.10% | 6.09% | -0.79% | -2.16% | 16.36% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Outset Medical | 28.48% | -95.12% | -98.48% | -98.48% | -98.48% | -98.48% |
| Abbott Laboratories | 17.14% | 29.54% | 19.14% | 186.83% | 452.07% | 515.10% |
Performance & Financial Health Analysis: Outset Medical vs Abbott Laboratories
| Metric | OM | ABT |
|---|---|---|
| Market Information | ||
| Market Cap | $237.18M | $229.31B |
| Market Cap Category | Micro cap | Mega cap |
| 10 Day Avg. Volume | 358,800 | 6,185,250 |
| 90 Day Avg. Volume | 320,190 | 7,383,993 |
| Last Close | $13.67 | $132.00 |
| 52 Week Range | $5.85 - $25.35 | $110.68 - $141.23 |
| % from 52W High | -46.07% | -6.54% |
| All-Time High | $1,004.40 (Nov 16, 2020) | $142.60 (Dec 27, 2021) |
| % from All-Time High | -98.64% | -7.43% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.07% |
| Quarterly Earnings Growth | 0.15% | 0.37% |
| Financial Health | ||
| Profit Margin (TTM) | -0.82% | 0.32% |
| Operating Margin (TTM) | -0.54% | 0.20% |
| Return on Equity (TTM) | -0.88% | 0.31% |
| Debt to Equity (MRQ) | 63.59 | 26.50 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.50 | $29.05 |
| Cash per Share (MRQ) | $10.36 | $4.18 |
| Operating Cash Flow (TTM) | $-67,542,000 | $9.04B |
| Levered Free Cash Flow (TTM) | $-35,191,248 | $5.92B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.28% |
| Last 12-Month Dividend | N/A | $1.69 |
Valuation & Enterprise Metrics Analysis: Outset Medical vs Abbott Laboratories
| Metric | OM | ABT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.36 | 16.53 |
| Forward P/E | -10.11 | 25.53 |
| PEG Ratio | 0.00 | 0.45 |
| Price to Sales (TTM) | 1.99 | 5.32 |
| Price to Book (MRQ) | 1.57 | 4.53 |
| Market Capitalization | ||
| Market Capitalization | $237.18M | $229.31B |
| Enterprise Value | $155.36M | $235.76B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.30 | 5.47 |
| Enterprise to EBITDA | -2.19 | 20.59 |
| Risk & Other Metrics | ||
| Beta | 2.14 | 0.71 |
| Book Value per Share (MRQ) | $8.50 | $29.05 |
Financial Statements Comparison: Outset Medical vs Abbott Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | OM | ABT |
|---|---|---|
| Revenue/Sales | $29.75M | $10.36B |
| Cost of Goods Sold | $18.69M | $4.47B |
| Gross Profit | $11.07M | $5.89B |
| Research & Development | $5.52M | $716.00M |
| Operating Income (EBIT) | $-16.40M | $1.69B |
| EBITDA | $-13.13M | $2.66B |
| Pre-Tax Income | $-25.67M | $1.78B |
| Income Tax | $115,000 | $453.00M |
| Net Income (Profit) | $-25.78M | $1.33B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | OM | ABT |
|---|---|---|
| Cash & Equivalents | $75.93M | $6.53B |
| Total Current Assets | $286.56M | $23.15B |
| Total Current Liabilities | $34.22M | $13.00B |
| Long-Term Debt | $96.32M | $12.74B |
| Total Shareholders Equity | $169.87M | $49.06B |
| Retained Earnings | $-1.12B | $47.72B |
| Property, Plant & Equipment | $10.50M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | OM | ABT |
|---|---|---|
| Operating Cash Flow | $-21.08M | $1.42B |
| Capital Expenditures | $-123,000 | $-484.00M |
| Free Cash Flow | $-25.79M | $933.00M |
| Debt Repayment | $-204.95M | $-1.00B |
| Common Stock Repurchase | N/A | $-280.00M |
Short Interest & Institutional Ownership Analysis
| Metric | OM | ABT |
|---|---|---|
| Shares Short | 2.16M | 18.33M |
| Short Ratio | 7.49 | 2.44 |
| Short % of Float | 0.12% | 0.01% |
| Average Daily Volume (10 Day) | 358,800 | 6,185,250 |
| Average Daily Volume (90 Day) | 320,190 | 7,383,993 |
| Shares Outstanding | 3.53M | 1.73B |
| Float Shares | 11.28M | 1.73B |
| % Held by Insiders | 0.03% | 0.01% |
| % Held by Institutions | 1.03% | 0.81% |
Dividend Analysis & Yield Comparison: Outset Medical vs Abbott Laboratories
| Metric | OM | ABT |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.69 |
| Last 12-Month Dividend Yield | N/A | 1.28% |
| 3-Year Avg Annual Dividend | N/A | $1.92 |
| 3-Year Avg Dividend Yield | N/A | 0.49% |
| 3-Year Total Dividends | N/A | $5.77 |
| Ex-Dividend Date | N/A | Jan 15, 2025 |